MedPath

Investigation about insulin doses and blood glucose control in changes from insulin glargine U-100 to insulin glargine U-300 for patients with diabetes.

Not Applicable
Conditions
diabetes mellitus
Registration Number
JPRN-UMIN000027364
Lead Sponsor
Dokkyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

1)The pregnant woman and/or a woman under breast-feeding. 2)The patient with intolerance of medical reasons by doctor. 3)The patients with hypersensitivity for insulin glargin U-300. 4)The patients with serious complications and considered inappropriate to participate in this study by the doctor in charge.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath